There were significant differences between the post-chemotherapy cancer subjects and the age-matched healthy women (stage 2 group) for AMH, the 1.5 (1.3) ng/mL being significantly higher (p < 0.001), and for FSH, the 6.2 (2.3) IU/L being significantly lower (p = 0.021) in the stage 2 healthy women, while no difference was found for E2. This evidence concerns the gene BRD2 and cancer.